✦ LIBER ✦

Inhibitors (I) Designed for Presenilin 1 by Means of Aspartic Acid Activation.

✍ Scribed by Gregor Larbig; Andrea Zall; Boris Schmidt

Book ID: 101967901
Publisher: John Wiley and Sons
Year: 2005
Weight: 11 KB
Volume: 36
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200506174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitors Designed for Presenilin 1 by

Inhibitors Designed for Presenilin 1 by Means of Aspartic Acid Activation. Preliminary Communication

✍ Gregor Larbig; Andrea Zall; Boris Schmidt 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 German ⚖ 168 KB

## Abstract __γ__‐Secretase, a multiprotein aspartic protease crucial to __Alzheimer__'s dementia, is not available for NMR experiments and has, so far, escaped crystallization. A positional scan of the aspartic protease by reactive probes may provide the necessary structural information for drug d

Identification of the histidine and aspa

Identification of the histidine and aspartic acid residues essential for enzymatic activity of a family I.3 lipase by site-directed mutagenesis

✍ Kwon Hyun-Ju; Kei Amada; Mitsuru Haruki; Masaaki Morikawa; Shigenori Kanaya 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 85 KB

[Methods and Principles in Medicinal Che

[Methods and Principles in Medicinal Chemistry] Aspartic Acid Proteases as Therapeutic Targets (GHOSH:PROTEASES DRUG TARG O-BK) || Peptidomimetic BACE1 Inhibitors for Treatment of Alzheimer's Disease: Design and Evolution

✍ Ghosh, Arun K. 📂 Article 📅 2011 🏛 Wiley-VCH Verlag GmbH & Co. KGaA ⚖ 371 KB

Corrigendum to: Identification of the hi

Corrigendum to: Identification of the histidine and aspartic acid residues essential for enzymatic activity of a family I.3 lipase by site-directed mutagenesis (FEBS 24210): [FEBS Letters 483 (2000) 139–142]

✍ Hyun-Ju Kwon; Kei Amada; Mitsuru Haruki; Masaaki Morikawa; Shigenori Kanaya 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 22 KB

High-density mutagenesis by combined DNA

High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I)

✍ A.Allart Stoop; Laurent Jespers; Ignace Lasters; Eric Eldering; Hans Pannekoek 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 430 KB

Screening of topoisomerase inhibitors fo

Screening of topoisomerase inhibitors for activity against human immunodeficiency virus: Inhibition by coumermycin A1 : G Tachedjian, D Tyssen, I Gust, S Locarnini and C Birch. Macfarlane Burnet Centre for Medical Research and Virology Department, Fairland Hospital, Yarra Bend Rd, Fairfield, Victoria 3078, Australia

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 25 KB